東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Managing metastatic prostate cancer ...

Balaji, K.C.

FindBook

Google Book

Amazon

博客來

Managing metastatic prostate cancer in your urological oncology practice

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Managing metastatic prostate cancer in your urological oncology practice/ edited by K.C. Balaji.
其他作者:	Balaji, K.C.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xiii, 280 p. :ill. (some col.), digital ;24 cm.
內容註:	Introduction -- Pathophysiology of Castration-Resistant Prostate Cancer -- Androgen Receptor Signaling in Castration Resistant Prostate Cancer -- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer -- Predictive Models in Castration Resistant Prostate Cancer -- Docetaxel in Advanced and Castration Resistant Prostate Cancer -- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate -- Cancer Vaccines in Castration Resistant Prostate Cancer – An evolution in design -- Abiraterone for the treatment of mCRPC -- Enzalutamide in Metastatic Castration Resistant Prostate Cancer -- Radium-223 in Metastatic Castrate Resistant Prostate Cancer -- Cabazitaxel for the Treatment of Prostate Cancer -- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer -- Bone Preservation Strategies for Men on Androgen Deprivation Therapy -- Novel Therapies in Castration-Resistant Prostate Cancer.
Contained By:	Springer eBooks
標題:	Prostate - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-3-319-31341-2
ISBN:	9783319313412

Managing metastatic prostate cancer in your urological oncology practice
Managing metastatic prostate cancer in your urological oncology practice[electronic resource] /edited by K.C. Balaji. - Cham :Springer International Publishing :2016. - xiii, 280 p. :ill. (some col.), digital ;24 cm.

Introduction -- Pathophysiology of Castration-Resistant Prostate Cancer -- Androgen Receptor Signaling in Castration Resistant Prostate Cancer -- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer -- Predictive Models in Castration Resistant Prostate Cancer -- Docetaxel in Advanced and Castration Resistant Prostate Cancer -- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate -- Cancer Vaccines in Castration Resistant Prostate Cancer – An evolution in design -- Abiraterone for the treatment of mCRPC -- Enzalutamide in Metastatic Castration Resistant Prostate Cancer -- Radium-223 in Metastatic Castrate Resistant Prostate Cancer -- Cabazitaxel for the Treatment of Prostate Cancer -- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer -- Bone Preservation Strategies for Men on Androgen Deprivation Therapy -- Novel Therapies in Castration-Resistant Prostate Cancer.

This text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strategies, outlines upcoming novel drugs and trends in research, and stresses the role of palliative care in this incurable disease. Managing Metastatic Prostate Cancer in Your Urological Oncology Practice will serve as a very useful resource for physicians and researchers dealing with, and interested in prostate cancer. It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and will include the most up to date scientific and clinical information.

ISBN: 9783319313412

Standard No.: 10.1007/978-3-319-31341-2doiSubjects--Topical Terms:

852653
Prostate
--Cancer

LC Class. No.: RC280.P7

Dewey Class. No.: 616.99463075

Managing metastatic prostate cancer in your urological oncology practice
LDR:02811nmm a2200313 a 4500 001 2036077
003 DE-He213
005 20160930102024.0
006 m d
007 cr nn 008maaau
008 161117s2016 gw s 0 eng d
020 $a 9783319313412 $q (electronic bk.)
020 $a 9783319313399 $q (paper)
024 7 $a 10.1007/978-3-319-31341-2 $2 doi
035 $a 978-3-319-31341-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.P7
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
082 0 4 $a 616.99463075 $2 23
090 $a RC280.P7 $b M266 2016
245 0 0 $a Managing metastatic prostate cancer in your urological oncology practice $h [electronic resource] / $c edited by K.C. Balaji.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xiii, 280 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Introduction -- Pathophysiology of Castration-Resistant Prostate Cancer -- Androgen Receptor Signaling in Castration Resistant Prostate Cancer -- Non-Androgen Signaling Pathways in Castration-Resistant Prostate Cancer -- Predictive Models in Castration Resistant Prostate Cancer -- Docetaxel in Advanced and Castration Resistant Prostate Cancer -- Combination Treatment Strategies with Docetaxel in Patients with Metastatic Prostate -- Cancer Vaccines in Castration Resistant Prostate Cancer – An evolution in design -- Abiraterone for the treatment of mCRPC -- Enzalutamide in Metastatic Castration Resistant Prostate Cancer -- Radium-223 in Metastatic Castrate Resistant Prostate Cancer -- Cabazitaxel for the Treatment of Prostate Cancer -- Sequencing Therapies in Metastatic Castration Resistant Prostate Cancer -- Bone Preservation Strategies for Men on Androgen Deprivation Therapy -- Novel Therapies in Castration-Resistant Prostate Cancer.
520 $a This text provides a comprehensive review of pathophysiology, molecular and cell biology aspects of CRPC, discusses all major clinical trials that have led to approval of 6 new drugs since 2004, explores the role of bone preservation strategies, in depth analysis of combination and sequencing strategies, outlines upcoming novel drugs and trends in research, and stresses the role of palliative care in this incurable disease. Managing Metastatic Prostate Cancer in Your Urological Oncology Practice will serve as a very useful resource for physicians and researchers dealing with, and interested in prostate cancer. It provides a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters are written by experts in their fields and will include the most up to date scientific and clinical information.
650 0 $a Prostate $x Cancer $x Treatment. $3 852653
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Urology. $3 636586
650 2 4 $a Oncology. $3 751006
700 1 $a Balaji, K.C. $3 2191938
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-31341-2
950 $a Medicine (Springer-11650)